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Previous studies have demonstrated that insulin, like other protein antigens, requires processing 
in metabolically active antigen-presenting cells (APC) before it can be recognized by class II-restricted 
~o lymphocytes. Unlike many other proteins, insulin peptides of minimal size retain the requirement 
r antigen processing. We demonstrate that this requirement can be bypassed by incubation 
of insulin with reducing agents in the presence of aldehyde-fixed APC. Fixed APC treated in 
this way were able to stimulate I-A  b- and I-Aa-restricted T cell hybridomas. Data are presented 
that demonstrate that cloned and polyclonal T cells recognize a determinant within the NHz- 
terminal 14 residues of the beef insulin A chain with no requirement for B chain residues. The 
common feature among peptides capable of stimulating these cells in the presence of live APC 
is the chemical form of the cysteine thiol groups. Those forms that produce free thiols upon 
reduction are active, whereas those with irreversibly protected sulfhydryls  are not. Functional 
experiments with fixed APC and competition binding experiments with purified I-A  d indicate 
that only A chain peptides with free thiols are able to stably associate with the peptide-binding 
site on class II in a form that is recognized by specific T cells. Our findings indicate that reduction 
of disulfide bonds is both necessary and sufficient for presentation of insulin to a major population 
of class II-restricted T cells. The results provide strong support for the hypothesis that protein 
disulfides can be reduced during physiologic antigen processing. 
O 
ne important function of the endocytic pathway in APC 
is to alter the structure of protein antigens so that they 
may interact with class II histocompatibility glycoproteins 
to form stable complexes that can be recognized by helper 
T  cells (1, 2).  It is generally observed that native proteins 
interact poorly with class II molecules. The requirement for 
antigen processing is operationally defined by an inability to 
stimulate appropriate T cells in the presence of aldehyde-fixed 
APC or by sensitivity of antigen presentation to agents that 
raise the pH of acidic intracellular organdies. In most in- 
stances, peptides derived from antigen can directly interact 
with class II and therefore do not require further antigen pro- 
cessing (3-7). 
Insulin has been an exception to this observation. Disulfide 
bond-containing peptides of insulin of minimal length to 
maintain antigenicity still require processing by the opera- 
tional definition. Naquet et al. (8) have described a minimal 
determinant comprised of residues A(1-14) disulfide linked 
to B(7-15) that was recognized by I-A  d- and I-Ab-restricted, 
loop-reactive T cell hybridomas. Further truncation or cleavage 
of disulfide bonds in this peptide destroyed its antigenicity. 
The authors concluded that the T cells recognized a confor- 
mational determinant containing essential residues from both 
the A and B chains of insulin. Others have described experi- 
ments in which mouse and human A chain loop-reactive  T 
cells were stimulated by A chain peptides with no associated 
B chain residues (9-13).  These results indicate that at least 
some loop-reactive T cells recognize determinants within the 
A chain. To date, no fragment of insulin has been identified 
that et~ciently stimulates T cells in the presence of fixed APC 
or inhibitors of antigen processing.  The case of insulin pro- 
vides an apparent paradox, where antigenic determinants of 
minimal size require further processing. Therefore, alterations 
other than proteolytic cleavage must occur during immuno- 
logic processing of insulin. 
In the present communication, we demonstrate that the 
minimal immunodominant  T cell determinant recognized by 
beef insulin-immune H-2  a  and  H-2  b  mice  is  contained 
within the A(1-14) segment of beef insulin and that the chem- 
ical status of one or more of the cysteine thiols is critical for 
maintaining peptide antigenicity. A chain peptides with free 
thiol groups are presented to T cells by fixed APC and there- 
fore do not require further immunological  processing. Results 
from experiments using purified I-A  d suggest that cysteine 
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tides with the peptide-binding site on class II and in recogni- 
tion by TCR. Our results support the hypothesis that the 
minimal processing event required for recognition of insulin 
by class II-restricted T cells is reduction of disulfide bonds, 
rather than cleavage by endopeptidases. 
Materials and Methods 
Cell Lines.  The Ia-positive  B call hybridoma, TH2.2 (14), was 
generously provided by Dr.  Richard Asofsky (Bethesda, ME)). 
TH2.2 expresses [-A  b, I-A  d, and I-E  d. Insulin-specific  T cell hy- 
bridomas were produced in this  laboratory (15) from beef in- 
sulin-immune BALB/cBy  and C57BL/10 SnJ mice. Bb-6.BC2 (Bb- 
6) is restricted by I-A  b and recognizes beef, but not pork, insulin. 
Bd-l.4 is restricted by I-A  a and is partially crossreactive with pork 
insulin. Cell lines were maintained in RPMI 1640 supplemented 
with  10%  FCS, 2 mM t-glutamine,  and 5  x  10 -s  M  2-ME 
(RIO). 
Culture Conditions and Lyraphokine Assay.  Cultures were per- 
formed  in flat-bottomed  96-well tissue  culture plates  in a final  volume 
of 0.2 ml R10. T cell hybridomas (10S/well) were cultured for 
24 h in the presence of various antigens and treated or untreated 
TH2.2 APC. Fixed TH2.2 were prepared by incubation in PBS 
containing 1% paraformaldehyde  for 15 min at 24~  followed by 
extensive  washing in serum-containing  media. Lymphokine  produc- 
tion, reflecting T cell activation, was quantitated by using the II., 
2-responsive cell line HT-2 (16). Culture supernatants (100/A) were 
subjected to one freeze/thaw cycle and cultured with 10  ~  HT-2 for 
40 h. Each well was pulsed with 1 #Ci of [3H]thymidine during 
the final 16 h of culture. The results represent the mean  _+  SD 
cell-associated cpm from triplicate cultures. 
Lymph Node Proliferation Assays.  Mice  were immunized sub- 
cutaneously  with 50/xg beef insulin or 25 ~g peptide in CFA. After 
9-11 d, draining lymph nodes were removed and single cell sus- 
pensions were prepared. Assays  were set up in 96-well tissue cul- 
ture plates using RPMI 1640 supplemented with 0.5%  normal 
mouse serum, 2 mM t-glutamine, 5 ￿  10 -5 M 2-ME, 100 U/ml 
penicillin, and 100 U/ml streptomycin. Plates were incubated for 
4 d at 37~  in a 5% CO2 atmosphere, and cultures were pulsed 
with 1/xCi [3H]thymidine  for the final 18 h. Results represent the 
mean  +  SD [3H]thymidine incorporation of triplicate cultures. 
Peptide Antigens.  All insulin peptides and derivatives used in 
this study were from the beef insulin sequence. Beef insulin (INS) 
was purchased from Elanco Products Co. (Indianapolis, IN). Per- 
formic acid-oxidized (oxlNS) and reduced and carboxyamido- 
methylated (rcamlNS) beef insulins were produced as previously 
described (17). The sulfonated A chain of beef insulin (A[SSO314) 
(18) was purified from sulfonated insulin by reverse-phase HPLC 
using a C4 column and a CH~CN gradient in 0.1% TFA. Purity 
was  confirmed  by  microsequencing.  The  peptides A(1-14), 
GIVEQCCASVCSLY; B(1-30), FVNQHLCGSHLVEALYLVCG- 
ERGFFYTPKA; B(17-30), LVCGERGFFYTPKA;  I(1-18), MDD- 
QRDLISNHEQLPILG; HEL(104-120), GMNAWVAWRNRC- 
KGTDVY;  HEL(105-120), MNAWVAWRNRCKGTDV;  and 
Myo(106-118), FISEAIIHVLHSR were synthesized in the Emory 
University  Microchemical  Facility  as previously  described (19). Cys- 
teine was incorporated into peptides using temporary S-p-metho- 
xybenzyl protection to produce free thiol groups after cleavage in 
liquid hydrogen fluoride. A(1-14)cm7 was synthesized with a per- 
manent S-acetamidomethyl protecting group in the A7 cysteine. 
A(1-14)cm6,7,11 was produced by reaction of A(1-14)cm7 with 
excess iodoacetamide.  Air-Qxidized  forms of A(1-14) and A(1-14)cm7 
were produced by stirring 0.5 mg/ml peptide in 50 mM Tris/HC1, 
pH 8.5, for 24 h at 24~ 
Class II Purification and Peptide-ln'nding Assay.  I-A  a and I-E  a 
were purified from detergent-sohbilized A20 B lymphoma mem- 
brane preparations as previously described (20). Solubilized mem- 
branes were passed sequentially through Sepharose-4b, mouse 
IgG-Sepharose, MKD6-Sepharose (16), and 14-4-4-Sepharose (21). 
Immunoaffinity  columns (2 ml) were prepared as described  by Gorga 
et al. (22). After loading, the columns were individually washed 
with 100-column volumes of 0.5% NP-40, 0.5 M NaC1, 50 mM 
Tris, pH 8.0, followed by 50 vol of 50 mM Tris, pH 8.0, and 10 
vol of 50 mM Tris, 0.15 NaC1, pH 8.0, containing 1% N-octyl- 
glucoside. Purified class II was eluted in 50 mM glycine, pH 11.0, 
containing 1% N-octylglucoside. The eluate was neutralized with 
1 M Tris, pH 7.0, dialyzed, concentrated, and stored at 4~  in 
1% N-octylglucoside. 
HEL(104-120) and Myo(106-118) were biotinylated by reaction 
with a 2.5 tool excess  of  biotin-amidocaproate  N-hydroxysuceinimide 
ester in N,N-dimetby] formamide, followed by acetone precipita- 
tion and HPIX2 purification (20). Biotinylated and unlabeled pep- 
tides were incubated with 40-80 nM I-A  a or bE  d at 37~  in a 
final volume of 30/A in the presence of 0.2% NP-40, 30-100 mM 
citrate/phosphate, I mM PMSF, and 2 mM EDTA. Sodium azide 
(0.01%) was included in some experiments. A sixfold molar excess 
of N-ethyl maleimide was added 60 min before immunoassay in 
experiments that included dithiothreitol (DTT) 1 during incuba- 
tion with peptide. Samples  were diluted to 200/~1 in 200 mM Tris, 
pH 7.5, containing 5% skim milk, 0.1% Tween  20, and 0.5% NP- 
40. Class lI/peptide  complexes were separated from flee peptide 
by incubation on microtiter assay plates coated with MKD6 (I- 
A  d) or 14-4-4 (I-E  a) mAb. Assay plates were prepared by incuba- 
tion with 50 #g/ml a~nity-purified goat anti-mouse Ig followed 
by incubation  with 50--200/xg/ml  purified  mAb. Plates  were blocked 
with 50 mM Tris, pH 7.5, containing 5% skim milk, 0.1% BSA, 
and 0.1% Tween 20, and thoroughly washed before sample addi- 
tion. Bound biotinylated peptide was detected by incubation with 
5/xg/ml avidin-alkaline  phosphatase for 60 min at 24~  followed 
by incubation with 1 rag/m1 p-nitrophenyl phosphate in 4 mM 
MgC12, 0.5 M Tris, pH 10.0, and measurement of ahsorbance at 
405 nm. Nonspecific  absorbance, measured  in the presence of excess 
unlabeled peptide, was generally <5% of the maximum value in 
the assay  and was equal to that observed  in the absence  ofbiotinylated 
peptide and independent of biotin-peptide concentration. Non- 
specific absorbance was subtracted from the results. Binding, as 
measured  by this assay,  reflects  the known specificity  of  peptide/class 
II interaction defined  by functional assays  and is saturable and dose 
dependent (20). 
Results 
Bypassing Insulin Processing  Requirements by Use of  Reducing 
Agents.  We have used the beef insulin-reactive T  cell hy- 
bridomas, Bd-l.4 and Bb-6, to define antigenic determinants 
recognized in association with |-A  d and I-A  b, respectively. 
These hybridomas appear  to be representative of the major 
polyclonal populations induced by beef insulin in H-2  a and 
H-2  b mice. Despite its relativdy small size, insulin must be 
processed in metabolically active APC before it can be recog- 
1  Abbreviation used in this paper: DTT, dithiothreitol. 
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hibited by chloroquine or prior fixation of APC. Disruption 
of the disulfide bonds in insulin by performic acid oxidation 
or reduction and alkylation destroys its capacity to stimulate 
cloned and polyclonal T  cells (8,  12,  13,  17).  This can be 
interpreted to indicate that an intact A chain loop structure 
or disulfide-linked B chain residues are essential components 
of the major determinant.  We have performed experiments 
with peptides derived from chymotrypsin and protease V8 
digests of insulin that indicate that while such peptides may 
retain the capacity to stimulate T cells in the presence of live 
APC,  they do not stimulate in the presence of fixed APC 
(data not shown). We therefore considered the possibility that 
the insulin determinant may be generated by cellular reduc- 
tion  of disulfide bonds. 
Indeed, the presence of reducing agent was found to ob- 
viate the need for live APC in the presentation  of insulin 
to class II-restricted T  cells (Table  1). Fixed TH2.2 B cells, 
incubated overnight in buffer containing insulin and 2 mM 
DTT,  were able to  activate Bb-6 and Bd-l.4  T  cells.  The 
reducing agent was necessary but not sufficient, in the ab- 
sence of insulin,  to mediate this effect. Similar results were 
obtained  with  reduced  glutathione  and  2-ME  (data  not 
shown). Two potential mechanisms were considered to ex- 
plain the observed effect of thiol reagents.  DTT might  act 
through reduction of one or more disulfide bonds in insulin, 
allowing reduced derivatives to interact directly with cell sur- 
face class II glycoproteins. Alternatively, reducing agents may 
activate cell surface proteins, such as thiol proteases,  that facili- 
tate the formation of functional insulin/class  II complexes. 
To address the latter possibility, fixed APC were treated with 
DTT, washed, and then exposed to insulin.  Pretreatment with 
DTT was not sufficient to allow presentation of insulin by 
fixed APC (Fig. 1 a). This result was consistent with a mech- 
anism involving reduction of disulfides in insulin rather than 
in cell surface proteins  associated with  the APC.  Optimal 
T cell responses were observed when APC were exposed to 
Table  1.  Bypassing the Insulin Processing Requirement 
by use of DTT 
APC treatment 
Antigen  DTT  APC  Bd-l.4  Bb-6 
cpm  ￿  10 -J 
INS  No  Fixed  3.8  +  3.7  1.3  +  0.1 
INS  Yes  Fixed  40.1  _+  1.2  40.1  _+ 8.7 
oxlNS  No  Fixed  2.1  _-!- 2.2  0.7  -+  0.1 
rcamlNS  No  Fixed  0.8  _+ 0.3  0.6  -+ 0.1 
INS  No  Live*  74.1  _+ 4.2  64.6  -+ 3.2 
Fixed TH2.2 were incubated with 40 #M antigen •  2 mM DTT in PBS 
for 18 h at 370C, washed, and cultured with T cells. Results represent 
lymphokine production. 
* T cells were cultured with live TH2.2 and 40 #M INS. 
insulin in the presence of 0.1-1 mM DTT, representing •  10- 
fold molar excess of DTT to insulin disulfides (Fig. 1 b). The 
concentration  of 2-ME used in tissue culture media (5  x 
10 -5 M) is not  sufficient to allow processing-independent 
presentation  of insulin. 
The Minimal T Cell Determinant Is Confined to the A  Chain 
of Insulin.  Various beef insulin derivatives were tested for 
their capacity to stimulate Bb-6 and Bd-l.4 T  cell hybrid- 
omas in  the presence of live APC.  A  chain  peptides were 
capable of stimulating these T  cells although their potency 
was generally reduced as compared to intact insulin.  Sulfo- 
nated A chain, with reversibly protected sulfhydryls, stimu- 
lated both I-A  b- and I-Aa-restricted T  cells to a level com- 
parable to that observed with 3-10-fold lower concentrations 
of intact insulin.  By contrast, rcamlNS (Fig. 2), oxlNS (Table 
1),  and the purified A  chain from oxlNS insulin  (data not 
shown) do not stimulate these T cells even at high concen- 
tration. The latter preparations have irreversibly protected A 
chain  thiol groups. 
The importance of the thiol moiety is further emphasized 
by a comparison of the potency of air-oxidized forms of the 
synthetic peptide A(1-14) and A(1-14)cm7. Alkylation of the 
A7 sulfhydryl destroys the stimulatory activity of this pep- 
tide. The air-oxidized preparation of the A(1-14) peptide has 
three  cysteine  thiols  that  form  intrachain  and  interchain 
disulfides producing a complex pattern on reverse-phase HPLC 
analysis. Air-oxidized A(1-14)cm7 is homogeneous on HPLC 
and contains a normal loop disulfide structure. The relative 
potency of these derivatives indicates that  the status of the 
A7 cysteine sulfhydryl, which participates in an interchain 
disulfide bond in insulin, is critical,  and that an intact loop 
is not sufficient for antigenicity.  Indeed, the activity of sul- 
fonated A chain suggests that an intact loop structure (23) 
is not an essential component of the T cell determinant.  The 
common feature distinguishing stimulatory from nonstimula- 
tory insulin derivatives is the capacity to regenerate free cys- 
teine thiol groups in the A chain by reduction. The reduced 
A(1-14) peptide, by contrast to air-oxidized preparations,  is 
essentially inactive  when  incubated  with  APC  in  serum- 
containing media. It is likely that the availability of this pep- 
tide is limited because of its potential reactivity with serum 
components.  Together these results indicate that  the min- 
imal determinant recognized by Bb-6 and Bd-l.4 is contained 
within the first 14 residues of the A chain of insulin with 
no requirement  for loop conformation or B chain residues. 
Presentation of A  Chain Peptides by Fixed APC.  The ca- 
pacity of the reduced form of A(1-14) to form stable com- 
plexes with I-A  b and I-A  a was demonstrated in experiments 
with fixed APC (Fig.  3). Fixed TH2.2 B cells were pulsed 
with various concentrations of A(1-14) in the absence of serum, 
washed, and cultured with T cell hybridomas. The presence 
of DTT during the peptide pulse did not affect the capacity 
of the treated APC to stimulate T  cells,  in contrast to our 
results with insulin.  This indicates that DTT does not mediate 
its effect on the presentation  of intact insulin  to Bb-6 and 
Bd-l.4 through alterations in the function of accessory mol- 
ecules involved in antigen presentation. If this were the case, 
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Figure  1.  Antigen presentation by 
fixed APC exposed to insulin and DTT. 
(a)  Fixed TH2.2 were  pretreated for 
24 h at 37~  in PBS in the presence or 
absence of 2 mM DTT as indicated. Ali- 
quots were washed and incubated for 
18 h with 20 #M INS in the presence 
(hatched bars) or absence (open bars) of 
2  mM DTT.  After  further washing, 
treated  TH2.2  (10  s)  were  cultured 
with 10~ Bd-l.4 T cells, and lympho- 
kine production  was measured as de- 
scribed in Materials and Methods.  (b) 
Fixed TH2.2 were incubated for 18 h 
at 37~  in PBS containing 33/~M INS 
and  various  concentrations  of DTT. 
After  washing, treated TH2.2  (2  ￿ 
10  s) were cultured with Bd-l.4 (open 
symbols)  or Bb-6 (closed symbols),  and 
lymphokine was measured. 
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Figure  2.  Specificity for an A chain 
determinant. Bb-6 (a) and Bd-l.4 (b) T 
cells  (10  s)  were  cultured  with  10  s 
TH2.2 and various  concentrations  of an- 
tigen. INS (O), A(SSO3)4 (O), oxA(1- 
14) (I),  A(1-14) ([3), rcamlNS (&), 
oxA(1-14)cm7 (A). Results reflect lym- 
phokine  production  as  described  in 
Materials and Methods. 
one would expect increased responses to the A(1-14) peptide 
after pulsing in the presence of DTT. Furthermore, it is evi- 
dence that the functional integrity of cell surface class II is 
not radically affected by DTT under the conditions used. How- 
ever, this result does not exclude the potential activation of 
cell  surface  enzymes  involved  in  processing  insulin.  The 
potency  of reduced  A(1-14)  is  equivalent  to  that  of  in- 
sulin/DTT  in  experiments  with  fixed  APC  (Fig.  3), 
confirming that all residues  necessary for T cell recognition 
and  MHC  association  are present within  the peptide. 
The importance of free thiols in the T  cell determinant 
was emphasized by the observation that disulfide reduction 
was required for presentation of air oxidized A(1-14) by fixed 
APC (Fig. 4, a and b). The requirement for DTT in the pre- 
sentation of oxidized A(1-14) strongly suggests that the effect 
of reducing agents on the presentation of insulin is a result 
of reduction of disulfide bonds in insulin rather than activa- 
tion of processing enzymes on the APC surface. It is evident 
that one or more free thiols in A(1-14) are required for inter- 
action with class II or recognition by the TCR.  The small 
response observed with Bd-L4 and oxidized A(1-14) may reflect 
a fraction of the peptide preparation bearing the appropriate 
free sulfhydryl  groups.  Our results  with A(1-14)cm7  (Fig. 
2)  suggested that the A7 thiol is important.  It is possible 
that the appropriate structure includes an intact loop disulfide 
in combination with a free thiol at A7.  However, it seems 
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Figure  3.  Reduced A(1-14) does not 
require processing. Fixed TH2.2 were 
incubated for 18 h at 37~  in PBS (a) 
or 0.15 M citrate/phosphate, pH 6 (b), 
with INS (O), INS + 2 mM DTT (O), 
A(1-14) ([~), or A(1-14)  +  DTT (I). 
Treated TH2.2 were washed and cul- 
tured with Bd-l.4 (a) or Bb-6 (b) T cells 
in separate experiments. The data rep- 
resent lymphokine production. 
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Figure 4.  Processing  requirements 
for reduced and oxidized A chain pep- 
tides. Fixed TH2.2 were incubated for 
18 h at 37~  in 0.15 M citrate/phos- 
phate, pH 5 (a and b) or pH 6 (c and 
d), with A(1-14)  (O), A(1-14) + 2 mM 
rrrT (o), oxA(1-14) (n), oxA(1-1a) 
+  DTT  (Ill),  A(SSO)3)4 (A),  or 
A(SSO3)4  + DTT (A). Treated TH2.2 
(10  s) were washed and cultured with 
10  s Bd-t.4 (a and c) or Bb-6 (b and d), 
and |ymphokine was measured. 
unlikely that a disulfide bond between the loop cysteines, A6 
and All, would form in reduced A(1-14) in the presence of 
DTT. Results similar to those obtained with air-oxidized A(1- 
14) were observed in experiments using sulfonated A chain. 
Fixed APC pulsed with sulfonated A chain in the presence, 
but not the absence, of DTT were capable of stimulating 
Bd-l.4 and Bb-6 (Fig.  4, c and d). 
Less time was required to generate functional antigen/class 
II complexes in the presence of DTT using A(1-14) as op- 
posed to intact insulin (Fig. 5). This may in part reflect the 
time required to reduce disulfides and generate the appro- 
priate structures necessary for binding class II (24). Binding 
was done at pH 6,  a condition that does not favor rapid 
disulfide reduction. In addition, partial precipitation of in- 
sulin and reduced B chain occurs under these conditions. We 
have previously reported that peptide/class II complex for- 
mation is favored at acidic pH (20,  25).  The observed ki- 
netics of functional antigen/class II complex formation may 
reflect a balance between the effects ofpH on antigen struc- 
ture and on class II ionization states that may be important 
for peptide loading. 
The Aft-N)  Determinant  Is Immunodominant  in 14-2  d and 
1-1-2  b Mice.  The results described above using cloned Bd-l.4 
and Bb-6 T  cell hybridomas are representative of those ob- 
tained with several other I-A  a- and I-Ab-restricted T cell hy- 
bridomas (data not shown). Polyclonal lymph node prolifer- 
ation assays were performed to determine whether the results 
obtained with the cloned T cells could be generalized to poly- 
clonal populations.  Beef insulin-immune H-2  d and  H-2  b 
lymphocytes respond well to A chain peptides, but not to 
B  chain  (Fig.  6).  The  air-oxidized  A(1-14) peptide  was 
significantly more potent in stimulating secondary in vitro 
proliferation than was insulin. Reciprocal experiments with 
1125  Jensen 
A(1-14)-immune lymphocytes demonstrated that insulin and 
A(1-14) are fully cross-reactive. The results of these experi- 
ments dearly indicate that A(1-14), without additional B chain 
residues, serves as a major immunodominant determinant in- 
duced by immunization with insulin in these haplotypes. We 
and others have previously reported that performic acid-oxi- 
dized insulin and rcamINS do not stimulate insulin-immune 
T cells in proliferation assays (8, 12, 13, 17). Therefore, the 
results of experiments using polyclonal T  cell populations 
are consistent with those obtained with T cell hybridomas. 
Binding  of Insulin  to Purified I-A d.  The data  presented 
above do not exclude potential thiol-dependent activation of 
processing enzymes on the surface of fixed APC that may 
act on intact insulin. To further address this possibility,  the 
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Figure 5.  Kinetics of reduced peptide association. Fixed A20 B cells 
were incubated with 10/~M INS  +  2 mM DTT (O),  10 #M A(1-14) 
+  DTT (Q), or DTT only (I) in 0.15 M citrate/phosphate,  pH 6, at 
37~  for the indicated time periods. The cells were washed, cultured with 
Bd-l.4, and T  cell lymphokine production was measured. ? 
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Figure 6.  Response  ofpolyclonal  T 
cells to A chain peptides. Lymph node 
lymphocytes from INS-primed (a and 
b)  or  oxA(1-14)-primed (c  and  d) 
BALB/c (a and c) or C57BL/10 (b and 
d) donors were cultured with various 
concentrations of INS (0), A(SSOs)4 
(O), oxA(1-14) (U), or B(1-30) (I-t) as 
described  in Materials  and Methods, and 
cell proliferation was measured. 
capacity  of insulin to inhibit the binding of a biotinylated 
peptide to purified I-A d was evaluated. We have recently  de- 
scribed an immunoassay for measuring the binding of bi- 
otinylated  peptide  to  purified class II  glycoproteins  (20). 
Binding, as measured by this assay, is saturable, inhibited by 
unlabeled peptide, and accurately reflects peptide specificity 
and pH dependence of complex formation as determined from 
functional assays. Insulin  inhibited  the binding  of biotin- 
Myo(106-118)  to purified  I-A  a only in the presence of DTT 
(Fig.  7 a). DTT alone did not inhibit peptide binding under 
these experimental conditions, consistent with the previously 
documented stability of class II. No inhibition was observed 
in experiments where insulin was added after an initial incu- 
bation of biotin peptide with I-A a (Fig.  7 b). This ruled out 
artifacts resulting from the potential effect of insulin/DTT 
in the immunoassay. DTT was neutralized with N-ethyl malei- 
mide before immunoassay  in these experiments.  Control pep- 
tides did not inhibit binding, indicating that competition is 
specific  (Fig.  7 c).  These results  support the interpretation 
that  reduced  insulin, but not intact  insulin, interacts  with 
the peptide-binding  site in I-A  d. 
The reduced  A(1-14)  peptide inhibited binding of biotin 
peptide to I-A d in the absence of reducing agent (Fig.  8 a). 
No competition was observed with the thiol-containing con- 
trol peptide, HEL(105-120). A(1-14)  inhibited the binding 
of biotin-HEL(104-120)  to I-E  d only at relatively  high con- 
centration, supporting the conclusion that A(1-14) interacts 
specifically with I-A  a (Fig. 8 b). T cells induced in H-2  a mice 
with beef insulin are generally restricted by IA  a and not IE  a 
(26).  The role of sulfhydryls  in MHC binding was further 
evaluated using alkylated  forms of A(1-14). A (1-14)cm7 re- 
tained  a capacity  to  efficiently  inhibit  binding  of biotin- 
Myo(106-120)  to I-A  a (Fig.  9). By contrast,  A(1-14)cm6,7,11 
was less effective in competition binding experiments. These 
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Figure  7.  Reduced  insulin inhibits binding of peptide antigen to purified I-A  a. (a) Purified I-A  a was incubated with 2/~M biotin-Myo(106-118) 
with various concentrations of INS in the presence (O) or absence (O) of 1 mM DTT for 48 h in duplicate, and biotin-peptide binding was measured 
by immunoassay as described in Materials and Methods. (b) Purified I-A  a was incubated with 2/~M biotin-Myo(106r118) and I mM DTT for 48 h 
in duplicate tubes. Insulin (40/~M) was added initially (pre) or 2 h before the immunoassay (post). (c) Purified  bA  d was incubated with 2/~M biotin- 
Myo(106-118), 1 mM DTT, and 40/kM INS, B(1-30), or I(1-18) as indicated for 48 h in triplicate tubes, and biotin peptide/l-A  a complexes were mea- 
sured by immunoassay. 
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Figure 8.  Inhibition  of biotin pep- 
tide binding with unlabeled  peptides. 
(a) Purified I-A  a was incubated with 
2 #M biotin-Myo(106-US)  in the pres- 
ence  of  various concentrations  of  unla- 
beled  peptides  for 48 h in duplicate, and 
binding was measured  by immunoassay 
as described  in Materials  and Methods. 
(b) Purified I-E  d was incubated with 
2/*M biotin-HEL(104-120). Uahbeled 
peptides: A(1-14) (O), HEL(105-120) 
(@), Myo(t06-118) (II). 
results, together with the functional experiments described 
above, suggest that the A7 cysteine thiol group may interact 
with the TCR,  whereas the A6 or All  (loop) thiols may 
be involved in interactions with class II. 
Discussion 
The data presented in this study demonstrate that a re- 
quirement for antigen processing can be bypassed by exposing 
fixed APC to insulin in the presence of reducing agent. Sev- 
eral experimental findings support the interpretation that the 
effect is mediated by reduction of insulin rather than APC 
membrane components. Pretreatment of fixed APC with DTT 
had no effect on a subsequent capacity to form insulin/class 
II complexes in the absence of reducing agent. An air-oxidized 
preparation of the minimal peptide, A(1-14), was not presented 
by fixed APC and therefore required further processing for 
functional association with class II. As with intact insulin, 
reduction of disulfides  in oxidized A(1-14)  with DTT was 
sufficient to bypass its processing requirement. No reducing 
agent was required for presentation for the reduced form of 
A(1-14) by fixed APC. More complex potential mechanisms 
were excluded in experiments using purified I-A  d. Intact in- 
sulin inhibited the binding of a biotinylated peptide antigen 
to  purified  I-A  a in  the presence, but  not  the absence,  of 
reducing agent. Under these experimental conditions, DTT 
can only act on insulin or class II. Results from functional 
None 
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Figure 9.  Importance  of A(1-14) thiol groups in I-A  a binding. Puri- 
fied I-A  a was incubated with 2/~M biotin-Myo(106-118)  in the presence 
of  unlabeled  peptides (80/tM) for 48 h in duplicate, and binding was mea- 
sured by immunoassay  as described in Materials and Methods. 
and binding experiments indicated that the reduced form of 
A(1-14)  could interact directly with class II in the absence 
of reducing agent to form stable complexes that could be rec- 
ognized by T cell hybridomas. We conclude that reduction 
of disulfide bonds in insulin is both necessary and sufficient 
to allow formation of functional insulin/class II complexes. 
It is evident that reducing agents, present in the concen- 
tration range used in this study, have no major effect on the 
function of class II glycoproteins. This is not surprising given 
the previous demonstration of the unusual stability of the 
class II molecule. The o~ and 3  subunits remain associated 
even in the presence of SDS and 2-ME. Recent evidence sug- 
gests that peptide antigen remains associated with the class 
II complex under these conditions (27, 28). It is possible that 
class II disulfides are not reduced under the experimental con- 
ditions used in this study. Alternatively, class II conforma- 
tion and function may be preserved after reduction of disulfide 
bonds. We cannot exclude the possibility that insulin pep- 
tides form covalent bonds that reduce cysteine in class II. This 
possibility seems unlikely because of the observed capacity 
of A(1-14) to bind class II in the absence of reducing agents, 
coupled with the lack of non-disulphide-linked cysteines in 
the extracellular domains of I-A  a and I-A  b (29,  30). 
The common feature among insulin derivatives capable of 
stimulating I-A  d- and I-Ab-restricted T  cells in the presence 
of live APC is the status of the cysteine thiols. Derivatives 
with disulfide bonds or sulfonated thiols are antigenic, whereas 
those with irreversibly protected sulfhydryl groups are not. 
We argue that previous results (8, 31), interpreted to suggest 
that disulfide-dependent conformation is an essential feature 
of the insulin determinant recognized by loop-reactive T cells, 
actually reflect a requirement for the potential to regenerate 
free sulfhydryl groups after reduction in antigen processing 
compartments. Results from polyclonal lymph node prolifer- 
ation assays support the conclusion that the major immuno- 
dominant determinant recognized by beef insulin-immune 
H-2  b and H-2  d T  cells is within A(1-14)  with no require- 
ment for disulfide-linked B chain residues. This conclusion 
is consistent with the results of Falcioni et al. (13), who demon- 
strated that >90% of a large panel of I-Ab-restricted  beef in- 
sulin-reactive T cell clones responded to sulfonated A chain 
but not performic acid-oxidized insulin. Gradehandt et al. 
(11,  32)  have  demonstrated  that  A~bA~-restricted clones 
recognize an A(1-14) determinant that is sensitive to performic 
acid oxidation.  It was proposed that processing of insulin 
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or conversion of disulfide bridges. Miller et al. (12) have de- 
scribed  loop-reactive  human T  cell lines  that  respond to 
disulfide forms, but not alkylated derivatives, of isolated A 
chain. 
By contrast, Naquet et al. (8) described a minimal peptide 
determinant, composed of A(1-14) disulfide linked to B(7- 
15), capable of stimulating loop-specific T cell hybridomas. 
Reduction or further proteolysis of this peptide markedly de- 
creased its antigenicity. The data presented by these authors 
supported the interpretation that the T  cells used in their 
study recognized a conformational determinant requiring 
residues from both the A chain and the B chain of insulin. 
Given the current findings, we suggest that the status ofcys- 
teine sulfhydryls,  rather than conformation maintained by 
disulfide bonds, is the critical element for antigenic@, A chain 
peptides with reversibly protected thiols were not used in 
their study. One finding reported in that study is inconsis- 
tent with this alternative  interpretation. The peptide A(1- 
14) disulfide linked to B(7-13) was inactive in antigen pre- 
sentation assays. This indicates that residues B14 or B15 are 
essential components of the minimal determinant. It is pos- 
sible that the T cell hybridomas used in the study of Naquet 
et al. (8) have a different specificity than those used in the 
present study. However, we argue that the majority ofT cells 
from H-2  a and H-2  b animals recognize a determinant that 
is completely contained within the A  chain. 
We emphasize that the data with fixed APC reported by 
Naquet et al. (8) suggest that even the minimal A(1-14)/B(7- 
15) peptide requires further processing. Evidence for further 
processing requirements of sulfonated and disulfide forms of 
A chain peptides were also provided by Miller et al. (12) in 
studies with human loop-specific T cell clones and those of 
Gradehandt et al.  (11, 32) using A~bAok-restricted clones. 
The first demonstration of efficient presentation of insulin 
peptides by fixed APC is provided by the current study. Results 
from functional experiments and binding studies suggest that 
the interchain A7 cysteine thiol is required for T cell recog- 
nition, but not for binding to I-A  a. By contrast, the loop 
thiols, B6 and/or All, appear  to interact with class II. 
It is known that the interchain disulfides are more readily 
reduced than is the loop disulfide. It is therefore conceivable 
that  partially reduced peptides containing an intact loop 
disulfide are the major substrates for formation of stable class 
II complexes. Observations that make this possibility less likely 
include the formation of functional complexes between re- 
duced A(1-14) and class II in the continued presence of DTT. 
Similarly, one would need to propose that loop structures 
are formed in sulfonated A  chain during incubation with 
reducing agents. However, the potential role of loop disulfides 
in class II binding cannot be excluded from the current data, 
and further experiments are in progress to address this issue. 
Phillips et al. (33) have demonstrated the binding of la- 
beled photoreactive bovine insulin to APC-associated class 
II glycoproteins. Binding was inhibited by unlabeled insulin, 
indicating that interaction with class II is not dependent on 
chemical modification of insulin. Insulin interacted with class 
II in a haplotype-unrestricted manner in their study. By con- 
trast, intact insulin did not inhibit the binding oflabded pep- 
tide antigen to purified I-A  a in the experiments described in 
the current study. Reduction of insulin disulfides was required 
for interaction with the putative peptide-binding groove. Pre- 
liminary studies from our laboratory (data not shown) sug- 
gest that biotinylated insulin can bind to I-A  d and FE  d in 
the absence of reduction. However,  this binding is not in- 
hibited by peptides known to form functional complexes with 
these class II glycoproteins and may reflect stable interaction 
of intact insulin with a monomorphic site on class II that 
is distinct from the peptide-binding groove. The functional 
significance of this interaction is unclear. We have previously 
described  T  cells  that recognize insulin in  an  MHC-un- 
restricted, class II-dependent fashion, and proposed that these 
cells recognize insulin associated with monomorphic deter- 
minants in class II (34). We have also measured binding of 
biotin  insulin  to  I-A  d in  the  presence  of  1  mM  DTT. 
Binding under these conditions, however, is inhibited by pep- 
tide antigens. 
Of the T cell determinants described in the literature, there 
are none with a weU-defined  requirement for an intact disulfide 
structure despite study of many disulfide-containing antigens. 
A number of linear  determinants have been described  that 
include cysteines involved in disulfide bridges present in the 
parent protein, It is therefore logical to suggest that a mech- 
anism exists to reduce protein disulfide bonds during antigen 
processing.  This mechanism must exist in a variety of cell 
types since insulin can be efficiently processed and presented 
to the T cells used in the current study by macrophages, B 
cells and transformed B  cells. Studies  with the disulfide- 
bonded, 18-amino acid peptide, apamin, indicate that disrup- 
tion of the disulfide bonds is generally  sufficient to bypass 
the antigen processing requirement and allows presentation 
of apamin to T cells by fixed APC (35). Rare (3/16) T cells 
fail to recognize apamin after reduction and alkylation, in 
the presence of live APC. This situation is analogous to that 
observed with loop-reactive insulin-specific T ceils. We would 
predict that reduction of disulfide bonds would allow pre- 
sentation of apamin to the disulfide-dependent T cell clones 
by fixed APC. For most situations, the status  of a cysteine 
thiols in T cell determinants does not appear to be critical. 
For example, alkylation of the sulfhydryl in HEL(104-120) 
does not affect its capacity to bind purified FE  d or to be rec- 
ognized by the appropriate T ceils (data not shown). In some 
situations, the chemical form of the thiol group may be im- 
portant for establishing appropriate interactions with the class 
II molecule or the TCR. This is analogous to the situation 
where amino acid substitutions are tolerated in some, but 
not all, positions in peptide determinants. 
The data provided in this communication provide strong 
evidence that disulfide bonds can be reduced during antigen 
processing. The mechanism and subcellular site of reduction 
remain to be determined. Very little information is available 
concerning the fate of protein disulfide bonds in proteins 
trafficking through the endocytic pathway.  A  number of 
studies using disulfide conjugates support the conclusion that 
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cling membrane proteins, including class II and the trans- 
ferrin receptor (36-38).  By contrast, other reports provide 
evidence for reducing activity in endocytic organeUes. Shen 
et al. (39) provided evidence for the release of methotrexate 
from endocytosed poly(D-lysine) conjugates using a disulfide 
spacer but not a triglycine spacer. The reduction of a labeled 
poly(D-lysine) disulfide conjugate after endocytosis was directly 
demonstrated in a subsequent study (40).  The site of reduc- 
tion was proposed to be the Golgi apparatus based on the 
results of subcellular fractionation experiments. Collins et 
al. (41) have recently demonstrated reductive cleavage of ot2- 
macroglobulin/transferrin conjugates in a compartment in 
macrophages that comigrates with lysosomes in density gra- 
dients.  The potential importance of lysosomes in  protein 
disulfide reduction is given further weight by the demon- 
stration of a lysosomal transport system that effxciently delivers 
cysteine from the cytoplasm into this compartment (42). The 
existence of this pathway was postulated earlier by Lloyd (43). 
The potential role of enzymes with protein disulfide reduc- 
tase activity (24, 44-46) remains undetermined. Convincing 
evidence for the localization of enzymes with this activity 
in vesicles in the endocytic pathway is not available. 
Reduction may play a major role as an initial step in the 
processing of disulfide-containing protein antigens. Reduc- 
tion of small polypeptides, such as insulin and apamin, can 
be sufficient to allow stable interaction with class II during 
antigen processing. With more complex proteins, reduction 
may help to unfold proteins allowing interaction of buried 
determinants with dass II (4, 47, 48) and facilitating cleavage 
by endopeptidases (41,  49,  50)  to generate linear peptides 
capable of stable  association with class II glycoproteins. 
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